THE CLINICAL ASSESSMENT OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PSORIATIC ARTHRITIS

被引：0
|
作者：
Isik, O. Ozdemir [1 ]
Cosan, F. [1 ]
Yazici, A. [1 ]
Cefle, A. [1 ]
机构：
[1] Kocaeli Univ, Div Rheumatol, Dept Internal Med, Med Fac, Kocaeli, Turkey
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1343
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0723
引用
收藏
页码：1151 / 1152
页数：2
相关论文
共 50 条
  • [1] Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
    Abdel Fattah N.S.
    Hassan H.E.
    Galal Z.A.
    El Okda E.S.E.
    [J]. BMC Research Notes, 2 (1)
  • [2] The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis
    Korendowych, E
    Owen, P
    Ravindran, J
    Carmichael, C
    McHugh, N
    [J]. RHEUMATOLOGY, 2005, 44 (08) : 1056 - 1060
  • [3] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES ARE A MARKER OF DISEASE SEVERITY IN PSORIATIC ARTHRITIS
    Korendowych, E.
    Owen, P. A.
    Lewis, J.
    Carmichael, C. R.
    Ravindran, J.
    McHugh, N. J.
    [J]. RHEUMATOLOGY, 2004, 43 : 121 - 121
  • [4] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES AND SHARED-EPITOPE PREVALENCE IN PSORIATIC ARTHRITIS
    Sellas, A.
    Barcelo, M.
    Farietta, R.
    Diez, B.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 619 - 619
  • [5] Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis
    Ouedraogo, D. -D.
    Palazzo, E.
    Nicaise-Roland, P.
    Somogyi, N.
    Grootenboer-Mignot, S.
    Hayem, G.
    Meyer, O.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (06) : 930 - 931
  • [6] Synovial fluid levels of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, Psoriatic Arthritis and Osteoarthritis
    Elkayam, O
    Anouk, M
    Golan, I
    Paran, D
    Kaufman, I
    Wigler, I
    Levartovsky, D
    Litinsky, I
    Caspi, D
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S165 - S165
  • [7] Association of anti-cyclic citrullinated peptide antibody with clinical features in patients with psoriatic arthritis
    Hagiwara, Shinya
    Tsuboi, Hiroto
    Terasaki, Toshihiko
    Terasaki, Mayu
    Toko, Hirofumi
    Shimizu, Masaru
    Honda, Fumika
    Yagishita, Mizuki
    Ohyama, Ayako
    Takahashi, Hiroyuki
    Yokosawa, Masahiro
    Asashima, Hiromitsu
    Kondo, Yuya
    Matsumoto, Isao
    Sumida, Takayuki
    [J]. MODERN RHEUMATOLOGY, 2020, 30 (02) : 365 - 372
  • [8] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY TESTING IN PATIENTS WITH PSORIATIC ARTHRITIS
    Korendowych, E.
    Brown, S.
    Jones, S.
    Lewis, J.
    Owen, P.
    Ravindran, J.
    McHugh, N. J.
    [J]. RHEUMATOLOGY, 2002, 41 : 115 - 115
  • [9] Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis
    Pinheiro, GC
    Scheinberg, MA
    da Silva, MA
    Maciel, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) : 234 - 235
  • [10] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers, V. Michael
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
12345